Texas 2025 - 89th Regular

Texas House Bill HB975

Voted on by House
 
Out of Senate Committee
 
Voted on by Senate
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

Impact

If enacted, HB 975 will create provisions for patients who have exhausted traditional treatment avenues and are seeking alternative options that might be life-saving. The law will protect eligible patients from state interference regarding their access to such treatments and will require that informed consent be thoroughly obtained prior to the commencement of any investigational treatment. This could empower patients and potentially shift the paradigm towards more personalized healthcare, while encouraging healthcare providers to consider innovative treatments for eligible patients.

Summary

House Bill 975 aims to establish a framework for patients with life-threatening or severely debilitating illnesses to access individualized investigational treatments. These treatments are defined as drugs, biological products, or devices tailored specific to an individual's genetic makeup. The bill emphasizes patient autonomy, allowing patients to explore treatment options that may not yet be widely approved or available, provided they meet specific criteria and have considered conventional treatments. The overarching goal is to grant patients the right to pursue innovative medical solutions, particularly in dire health circumstances.

Contention

Despite its beneficial intent, the bill has raised concerns regarding the ethical implications and the responsibilities of healthcare providers. Critics are wary of situations where patients may opt for treatments that lack sufficient evidence of effectiveness or safety, raising questions about the regulatory oversight of such investigational therapies. Additionally, the provision indicating that patients must assume financial liability for their treatments adds a layer of contention, particularly regarding patients who might not be able to afford these potentially costly options. As debate continues, the balance between patient rights and safety remains a focal point in the discussions surrounding HB 975.

Companion Bills

TX SB984

Similar Relating to access to individualized investigational treatments for patients with life-threatening or severely debilitating illnesses.

Previously Filed As

TX HB4059

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX HB4348

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX SB1580

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX HB638

Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.

TX SB773

Relating to access to certain investigational drugs, biological products, and devices used in clinical trials by patients with severe chronic diseases.

TX HB1200

Relating to authorizing the possession, use, cultivation, distribution, transportation, and delivery of medical cannabis for medical use by qualifying patients with certain debilitating medical conditions and the licensing of dispensing organizations and cannabis testing facilities; authorizing fees.

TX SB121

Relating to authorizing the possession, use, cultivation, distribution, delivery, sale, and research of medical cannabis for medical use by patients with certain medical conditions and the licensing of medical cannabis organizations; authorizing fees.

TX SB297

Relating to hospital patients' rights and hospital policies and procedures; providing an administrative penalty.

TX SB1724

Relating to advance directives and health care treatment decisions made by or on behalf of patients, including a review of those directives and decisions.

TX SB1952

Relating to advance directives and health care treatment decisions made by or on behalf of patients, including a review of those directives and decisions.

Similar Bills

AZ SB1163

Individualized investigational treatment; availability; prohibitions

TX HB4348

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX SB1580

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX HB4059

Relating to the right to try cutting-edge treatments for patients with life-threatening or severely debilitating illnesses.

TX HB3318

Relating to access to individualized investigational treatments for patients with life-threatening or severely debilitating illnesses.

TX SB984

Relating to access to individualized investigational treatments for patients with life-threatening or severely debilitating illnesses.

TN SB0282

AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to medical treatment.

TN HB0192

AN ACT to amend Tennessee Code Annotated, Title 53 and Title 63, relative to medical treatment.